HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
2276studies shown
Showing 889-900 of 2,276
Device study icon
CompletedACTRN12620000890932

A multisite study of repetitive transcranial magnetic stimulation (rTMS) for social communication in autism spectrum disorder (ASD).

Official study title

Does repetitive transcranial magnetic stimulation (rTMS), compared to sham rTMS, improve social communication in adolescents and young adults with autism spectrum disorder (ASD)?

This study has finished and is no longer accepting participants.

In Australia
Mental healthInterventional studyAges 14–40
Countries
Australia
Sponsor
Deakin University
Other study type icon
CompletedNCT01959659

A Non-Interventional Study of people with Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness

What is this study about?

This completed observational study examined healthcare use and the impact of persistent schizophrenia symptoms despite adequately dosed antipsychotic treatment.

This study has finished and is no longer accepting participants.

In Australia
SchizophreniaObservational studyAges 18+
Countries
Australia, France, Czechia, + 4 others
Sponsor
Hoffmann-La Roche
Other study type icon
CompletedACTRN12617001140347

A nutrient combination in the treatment of OCD

Official study title

Treatment of Refractory Obsessive-Compulsive Disorder with Nutraceuticals

This study has finished and is no longer accepting participants.

In Australia
OCDInterventional studyAges 18–75
Countries
Australia
Sponsor
Prof Jerome Sarris
Drug study icon
CompletedACTRN12619001485123

Safety study of pharmacokinetics, Pharmacodynamics, and Safety of Oral Etifoxine in Anxiety

Official study title

A Phase 1, Two Stage, Double-Blind, Placebo-Controlled Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Oral Etifoxine in Normal Healthy Volunteers

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 18–65
Countries
Australia
Sponsor
Gaba Therapeutics Australia Pty Ltd a subsidiary of Gaba Therapeutics, Inc
Drug study icon
TerminatedNCT02827513

Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) in Young Healthy Subjects

Official study title

A Phase 1 Study to Investigate the Safety, Tolerance, Food Effect, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of Extended Release Formulations of Centanafadine (CTN) (Formerly Called EB-1020) in Young Healthy Subjects

This study ended early.

In Australia
ADHDMedication studyAges 18–45
Countries
Australia
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedACTRN12624000547549

Safety study of Safety and Pharmacokinetics of a Single Intravenous Infusion of TRP-8803 (Psilocin) in Mental health

Official study title

A Phase 1, Open-label, Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of a Single Intravenous Infusion of TRP-8803 (Psilocin) in Healthy Adult Participants

This study has finished and is no longer accepting participants.

In Australia
Mental healthInterventional studyAges 18–55
Countries
Australia
Sponsor
Tryp Therapeutics, Inc.
Drug study icon
CompletedACTRN12625001127493

Safety study of CBD Inhalation Aerosol in Anxiety

Official study title

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of CBD Inhalation Aerosol in Healthy Adult Volunteers

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 18–65
Countries
Australia
Sponsor
InhaleRx Ltd.
Drug study icon
CompletedACTRN12618001042235

R-107 for treatment-resistant depression

Official study title

A Phase 2a Proof-of-Concept Study of R-107 for the Treatment of Refractory Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 18–80
Countries
Australia, New Zealand, Singapore, + 1 other
Sponsor
Douglas Pharmaceuticals Ltd.
Other study type icon
CompletedACTRN12618001059257

A feasibility study examining therapeutic choirs designed to improve wellbeing and relationship quality for community-dwelling people with dementia and their family caregivers

Official study title

A pilot feasibility trial examining therapeutic choirs designed to improve wellbeing and relationship quality for community-dwelling people with dementia and their family caregivers

This study has finished and is no longer accepting participants.

In Australia
Mental healthInterventional studyAges 18+
Countries
Australia
Sponsor
The University of Melbourne

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.